Bionano Genomics (BNGO) Capital Expenditures Growth (3y) (2021 - 2026)
Bionano Genomics (BNGO) Capital Expenditures Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 129.26 Bn | 124.05 Bn | 1.96 Bn | -29.93% |
| 2 | Becton Dickinson | 46.23 Bn | 45.42 Bn | 2.15 Bn | -11.61% |
| 3 | Alcon | 33.66 Bn | 32.00 Bn | 1.53 Bn | -10.15% |
| 4 | Medline | 33.07 Bn | 30.84 Bn | 1.84 Bn | - |
| 5 | Resmed | 30.36 Bn | 28.70 Bn | 890.98 Mn | 5.31% |
| 6 | West Pharmaceutical Services | 24.00 Bn | 23.56 Bn | 329.20 Mn | -16.94% |
| 7 | Solventum | 14.89 Bn | 14.33 Bn | 1.10 Bn | 8.92% |
| 8 | Cooper Companies | 13.96 Bn | 13.82 Bn | 735.40 Mn | 5.49% |
| 9 | Baxter International | 12.52 Bn | 10.51 Bn | 891.00 Mn | -6.01% |
| 10 | Bionano Genomics | 12.06 Mn | -1.63 Mn | 3.25 Mn | -26.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.92% |
| Jun 30, 2025 | 33.82% |
| Mar 31, 2025 | -33.82% |
| Dec 31, 2024 | -111.74% |
| Jun 30, 2024 | 0.44% |
| Dec 31, 2022 | 306.70% |
| Sep 30, 2022 | 209.17% |
| Jun 30, 2022 | -240.91% |
| Mar 31, 2022 | 202.69% |
| Dec 31, 2021 | 24.36% |
| Sep 30, 2021 | 16.49% |
| Jun 30, 2021 | -13.80% |